

Nerve Access, Inc.
$5B effective Alzheimer's therapeutic, FDA placed on expedited approval pathway, $3MM needed to file IND and conduct clinical Phase IIa.
- Stage Product In Development
- Industry Biotechnology
- Location United States
- Currency USD
- Founded July 2008
- Employees 6
- Website nerveaccess.com
Company Summary
Nerve Access, Inc. is a biotechnology company that was founded to conduct quality research and manufacturing of pharmaceuticals and other medical products, with a special focus on therapeutics that can enhance regeneration and functional recovery of the Central Nervous System (CNS) after neurological disorders such as Alzheimer's, stroke, Parkinson's, spinal cord injury, multiple sclerosis, and traumatic brain injury.
Team
-
Yaser A MaksoudPresident & CEO
- Neurosurgeon, and neuroscientist who graduated from Zagazig University in Egypt in 1994.
- Worked in the field of Neurosurgery (1995-1999) in Egypt. - Moved to Chicago in 1999 where he did a postdoctoral fellowship at Neurosurgery, University of Illinois at Chicago.
- Taught biomedical science to graduate and undergraduate students in Chicago (2002-2006).
- Founded Neural Repair Institute (2006) and Nerve Access (2008). -
Tony Giordano, PhDDirector, Drug Development
- Experienced Entrepreneur, President or V.P. of 6 biotech companies
- Has been involved in development of four clinical products -
Mustafa Maher, RphDirector, Drug Formulation
- Senior Compounding Pharmacist, Women’s International Pharmacy
- Over twenty six years of formulation experience
Advisors
-
Aaron F. Barkoff, Ph.D., Partner, McAndrews, Held & Malloy, Ltd., Intellectual Property CounselLawyerUnconfirmedAbbassi AccountingAccountantUnconfirmed
Previous Investors
-
Founder/FamilyUnconfirmedFederal GrantsUnconfirmed
Starting a startup?
Join the world's largest startup network for guidance, tools, and fundraising opportunities.